Immediate Impact
1 from Science/Nature 26 standout
Citing Papers
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
2023 Standout
Works of A. Madroszyk being referenced
OA15.02 Carboplatin-Etoposide Versus Topotecan as Second-Line Treatment for Sensitive Relapsed Small-Cell Lung Cancer: Phase 3 Trial
2019
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Madroszyk | 83 | 53 | 32 | 58 | 4 | 114 | |
| Anwar Ahmad | 92 | 40 | 9 | 100 | 6 | 164 | |
| Yan-Fang Ye | 76 | 44 | 29 | 101 | 7 | 167 | |
| Chun-Yen Ou | 29 | 45 | 15 | 67 | 6 | 199 | |
| R. Cavagnini | 72 | 123 | 11 | 162 | 5 | 208 | |
| Bharat Mocherla | 27 | 32 | 12 | 63 | 4 | 167 | |
| Å. Bratland | 168 | 50 | 90 | 53 | 4 | 219 | |
| Changdong Lu | 44 | 23 | 55 | 36 | 4 | 151 | |
| Shen-Chih Chang | 59 | 17 | 16 | 49 | 7 | 199 | |
| L. Bozec Le Moal | 96 | 85 | 6 | 102 | 6 | 157 | |
| Shie-Lee Cheah | 82 | 66 | 7 | 163 | 4 | 190 |
All Works
Loading papers...